Revelation Biosciences Inc. Receives Approval to Start a Phase 1 Clinical Study of REVTx-99 an Experimental Treatment for COVID-19

MENLO PARK, Calif.--(BUSINESS WIRE)-- #biotechnews--Revelation Biosciences Inc. Receives Approval to Start a Phase 1 Clinical Study of REVTx 99 an Experimental Treatment for COVID 19

Click to view original post